Skip to content

Innovative Laser for Retinal Diseases

R:GEN is an Innovative Laser Solution for Common Retinal Diseases offering:

  • Selective Retina Therapy

  • 527 nm wavelength & 1.7 µs pulse duration

  • Ramping Technology

  • Real Time Feedback Technology

View Publications
R_Gen Patient

Regulatory Approvals

R:GEN Vision carries the CE Mark and is FDA Approved

Real-time Feedback Technology

R:GEN® utilizes optoacoustic and reflectometry to ensure the appropriate treatment energy. Real-Time Feedback technology detects sound wave & back scattering light from RPE microbubbles generated by laser and irradiation automatically stops when microbubble formation is detected.

Reflectometry
Reflectometry
Optoacoustic
Optacoustic
Core Technology HR

Disposable RTF Sensor

 

The RTF sensor enables selective retinal treatment by detecting the pressure wave of microbubble generated after irradiation with R:GEN® laser.

The Core Technology includes Patented solutions Ramping and Feedback.

 

Ideal Wavelength

Ideal Wavelength and Pulse Duration

 

The R:GEN® with 527 nm wavelength and 1.7 μs pulse width is ideal for selectively damaging RPE cells while sparing other retinal tissues.

 

Ramping Technology

Ramping Technology

 

R:GEN® rapidly produces 15 laser pulses with ramping up energies to check the optimal pulses for the patient.

 

MoA

How R:GEN® works

 

When problematic RPE cells are treated by R:GEN®, the irradiated RPE cells are destroyed without damaging
neighbor photoreceptors. Subsequently, RPE cell regeneration is induced which results in improvement of the retinal metabolism.

 

RPE Generation

RPE Regeneration

 

RPE layer is recovered with RPE cell migration and regeneration.

 

Want to Learn More?

Get in touch